Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ACTRN12626000703303) titled 'Pilot Randomised Clinical Trial of best practice wound management practice using OPAL X cream or standard moisturising creams in residential aged care facilities' on June 12.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Other
Type of endpoint: Efficacy
Primary Sponsor: OPAL X Therapeutics Pty Ltd
Condition:
skin tears
skin ulcers
Quality of undamaged skin, and resistance to new skin tears after 12 weeks of regular use
skin tears
skin ulcers
Quality of undamaged skin, and resistance to new skin tears ...